<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04942353</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00004656</org_study_id>
    <nct_id>NCT04942353</nct_id>
  </id_info>
  <brief_title>Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients</brief_title>
  <acronym>MOVE-LVAD</acronym>
  <official_title>Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3TM Patients: A Randomized Controlled Pilot Study (MOVE-LVAD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To demonstrate that home-based exercise rehabilitation (HER) compared to usual care (UC)&#xD;
      results in a significant reduction in healthcare utilization in HeartMate 3 (HM3) left&#xD;
      ventricular assist device (LVAD) patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean number of clinic visits</measure>
    <time_frame>1 year</time_frame>
    <description>Healthcare utilization will be measured as the sum of all-cause rehospitalizations, outpatient VAD Clinic visits and emergency room visits room visits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean number of days out of the hospital</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in the number of daily steps taken</measure>
    <time_frame>1 year</time_frame>
    <description>Steps will be tracked using the Garmin watch. The Garmin watch uses Global Positioning System (GPS) tracking and an accelerometer to continuously monitor activity and provides data on average number of steps per day.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change 6-minute walk distance</measure>
    <time_frame>baseline to 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change in number of participants with improved quality of life</measure>
    <time_frame>baseline to 1 year</time_frame>
    <description>Quality of life will be measured using the Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12). The scale ranges from 12-70 with higher scores indicating better quality of life.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <condition>Left Ventricular Dysfunction</condition>
  <arm_group>
    <arm_group_label>Home-based Exercise Rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home-based Exercise Rehabilitation.</intervention_name>
    <description>Based on physical therapist or exercise physiologist assessment, subjects will receive an individualized exercise prescription for frequency, duration, and intensity of walking and strength training (including exercises using light-weight hand-weights and upper and lower body exercises using resistance bands). Research team will provide updated exercise prescription based on Garmin watch/Datos app activity data and Datos app data (including Borg scale).</description>
    <arm_group_label>Home-based Exercise Rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Patients receive a standardized recommendation to increase their walking activity to 30 minutes 5 days/week.</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  â‰¥ 18 years of age on the date of randomization&#xD;
&#xD;
          -  Patient implanted with a new HeartMate 3 LVAD at URMC&#xD;
&#xD;
          -  Patients enrolling in the study at the time of index discharge home following new HM3&#xD;
             LVAD implantation will be evaluated by a HF cardiologist and physical therapist and&#xD;
             will need to demonstrate ability to ambulate independently. Patients enrolling in the&#xD;
             study after their index discharge home following HM3 LVAD implantation will be&#xD;
             evaluated by a HF cardiologist or VAD Coordinator and will need to demonstrate ability&#xD;
             to ambulate independently.&#xD;
&#xD;
          -  Patient willing to participate in HER.&#xD;
&#xD;
          -  Patient owns a smartphone with Internet connection.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major comorbidities or limitations that may interfere with exercise training&#xD;
             (including significant orthopedic/neurologic limitations, decompensated HF,&#xD;
             uncontrolled arrhythmias, unstable angina).&#xD;
&#xD;
          -  Patient with a life expectancy &lt;12 months.&#xD;
&#xD;
          -  Patient unwilling to sign the consent for participation.&#xD;
&#xD;
          -  Patient unwilling or unable to cooperate with the study protocol&#xD;
&#xD;
          -  Patient who does not anticipate being a resident of the area for the scheduled&#xD;
             duration of the research study&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lori Caufield</last_name>
    <phone>585 - 273 - 4956</phone>
    <email>lori_caufield@urmc.rochester.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Himabindu Vidula</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

